VENORUTON CAPSULES 300 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
MONOXERUTIN 300 MG
Available from:
NUTRITION CONSUMER HEALTH
ATC code:
C05CA02
Pharmaceutical form:
CAPSULES
Administration route:
PER OS
Manufactured by:
NOVARTIS CONSUMER HEALTH SA, SWITZERLAND
Therapeutic group:
MONOXERUTIN
Therapeutic indications:
For the adjunctive treatment of varicose veins in all stages.
Authorization date:
2009-09-01
